Celltrion said on the 2nd that it launched the subcutaneous infliximab formulation Remsima SC in Chile, the first entry into the Latin American public market. The company's Chile subsidiary held ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback